IL-10 production in circulating T cells differs between allergen-induced isolated early and dual asthmatic responders - 01/09/11
Abstract |
Background: IL-10 is an anti-inflammatory cytokine released from various cells, including T cells. The role of IL-10 in asthma pathogenesis remains uncertain. Allergen inhalation by atopic asthmatic subjects results in 2 bronchoconstrictor phenotypes: isolated early response and dual response. Persistence of allergen-induced airway inflammation is a feature of dual responders. Objectives: The kinetics of IL-10 production in circulating T cells were investigated to examine a potential role of IL-10 in allergen-induced responses and airway inflammation. Methods: Fourteen subjects with mild asthma (7 isolated early and 7 dual responders) were challenged with allergen. PBMCs taken before and 24 hours after allergen challenge were processed for intracellular IL-10 staining with fluorescent-conjugated anti-IL-10 antibody. The frequency of IL-10-producing cells was assessed for CD4+ and CD8+ T-cell subsets by using flow cytometry. Results: Before allergen administration, the frequency of IL-10-producing CD4+ cells was significantly higher in dual than in isolated early responders. IL-10-producing CD4+ cells significantly increased after allergen in early responders, whereas IL-10-producing CD4+ cells significantly decreased in dual responders. Simultaneous assessments of IL-5-producing T cells did not show any differences between each group before or after allergen administration. Conclusions: These results suggest that the contrasting profiles of IL-10 production may be associated with the different time course of allergen-induced airway inflammation between allergen-induced early and dual responders. (J Allergy Clin Immunol 2002;109:281-6.)
Le texte complet de cet article est disponible en PDF.Keywords : IL-10, IL-5, allergens, asthma, early responders, dual responders
Abbreviations : BAL:, GSEM:, IQR:
Plan
Supported by the Canadian Institutes of Health Research, the Japan Heart Foundation, and Bayer Yakuhin Research Grant Abroad. |
|
Reprint requests: Paul M. O'Byrne, MB, Firestone Institute for Respiratory Health, St Joseph's Healthcare, 50 Charlton Ave East, Hamilton, Ontario L8N 4A6, Canada. |
Vol 109 - N° 2
P. 281-286 - février 2002 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?